《大行》中金升药明生物(02269.HK)目标价至22.5元 料今年呈加速态势

阿斯达克财经
Jan 17, 2025

中金发表报告指,药明生物(02269.HK) 参加第43届摩根大通医疗健康大会,CEO陈智胜向投资者更新业务近况以及2025年展望。公司维持2024年指引不变,包括5至10%收入增长,8至14%扣新冠收入增长;并预计2025年业务势头呈现加速态势。另外,营运效率提升,管理层预计2025年利润率提升100至150个点子。报告指,由于公司新签项目数量强劲增长,PPQ项目储备丰富有望放量,上调2024至...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10